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Abstract 
Dry powders containing a live-attenuated Newcastle disease vaccine (LZ58 strain) and intended 
for mass vaccination of poultry were prepared by spray drying using mannitol in combination 
with trehalose or inositol, polyvinylpyrrolidone (PVP) and/or bovine serum albumin (BSA) as 
stabilizers. These powders were evaluated for vaccine stabilizing capacity during production 
and storage (at 6ºC and 25ºC), moisture content, hygroscopicity and dry powder dispersibility. A 
mixture design, varying the ratio of mannitol, inositol and BSA, was used to select the stabilizer 
combination which resulted in the desired powder properties (i.e. good vaccine stability during 
production and storage, low moisture content and hygroscopicity and good dry-dispersibility). 
Inositol-containing powders had the same vaccine stabilizing capacity as trehalose powders, but 
were less hygroscopic. Incorporation of BSA enhanced the vaccine stability in the powders 
compared to PVP-containing formulations. However, increasing the BSA concentration 
increased the hygroscopicity and reduced the dry dispersibility of the powder. No valid 
mathematical model could be calculated for vaccine stability during production or storage, but 
the individual experiments indicated that a formulation combining mannitol, inositol and BSA in a 
ratio of 73.3:13.3:13.3 (wt/wt) resulted in the lowest vaccine titre loss during production (1.6-2.0 
log10 50% egg infectious dose (EID50) and storage at 6ºC (max. 0.8 log10 EID50 after 6 months) in 
combination with a low moisture content (1.1-1.4%), low hygroscopicity (1.9-2.1% water uptake 
at 60% relative humidity) and good dry-dispersibility properties. 
1. INTRODUCTION 
 
In poultry farming spray- and aerosol vaccinations are frequently used as mass vaccination 
methods against various viral respiratory diseases amongst which Newcastle disease (ND) is 
most significant [1, 2]. After reconstitution of the freeze-dried vaccine cake in water, the vaccine 
dispersion is nebulized throughout the poultry house followed by inhalation of vaccine particles 
by the birds. The efficiency of this method can be greatly reduced by a number of factors: 1) the 
currently used liquid vaccine nebulizers generate sprays or aerosols with wide droplet size 
distributions, reducing the inhalable fraction of vaccine particles. Moreover, in case of primary 
vaccination of young birds, fine respirable vaccine particles produced during spraying may 
cause severe post-vaccination reactions [3, 4]; 2) after nebulization the airborne vaccine 
droplets evaporate, leading to vaccine inactivation and uncontrolled vaccine particle size 
spectra [5-7] and 3) the tap water used for vaccine reconstitution cannot stabilize the vaccine 
sufficiently [6, 8] and is often contaminated with viricidal agents such as chlorines. 
In order to circumvent mentioned drawbacks monodisperse dry powder vaccines may 
represent a better alternative for current liquid spray and aerosol vaccines in which case the 
ideal powder vaccine should meet the following requirements: 1) show no or only limited virus 
loss during production and storage; 2) be monodisperse; 3) have a size that will enable 
exclusive targeting of the high respiratory tract for primary vaccinations or the lower respiratory 
airways for secondary (booster) vaccinations; 4) be easy to disperse into their primary particle 
size; 5) be non-hygroscopic to prevent hygroscopic growth of the vaccine virus particles in the 
airways during respiration [9] and 6) is non-toxic for man, animals and environment. 
Milling of freeze-dried ND vaccines enabled Fournier and Gaudry to successfully produce 
powder ND vaccines [10, 11]. However, this technique did not allow the manufacturing of 
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powder vaccines with narrow-sized particle spectra. In contrast, Corbanie and others were able 
to improve the monodispersity of ND powder vaccines by means of spray drying [12]. Although 
the newly produced spray dried powder vaccines consisting of trehalose with 
polyvinylpyrrolidone (PVP) and/or bovine serum albumin (BSA) stabilized the ND vaccine during 
spray drying, they were highly hygroscopic and significant virus losses were observed during 
storage. An exception was the low hygroscopic mannitol powder vaccine which was stable 
during storage, but suffered from severe vaccine virus titre loss during spray drying [12].  
Therefore, further improvement of spray dried powder vaccines regarding vaccine stability, 
hygroscopicity and dispersibility, was attempted in a series of studies. At this stage it was not 
the aim to produce powder vaccines with defined particle sizes and a narrow span.  
To combine the stabilizing properties of the carriers used by Corbanie during spray drying 
and storage, in this study mannitol was spray dried with trehalose and PVP and/or BSA. In order 
to minimize hygroscopicity, the formulation mainly consisted of mannitol. Inositol, a low 
hygroscopic sugar, was introduced as a new stabilizer as substitute for trehalose in the powder 
formulation. After preliminary experiments focusing on vaccine stability, dry-dispersibility and 
hygroscopicity, the optimization of a selected ND vaccine formulation was investigated in the 
main experiments. 
 
2. MATERIALS AND METHODS 
 
2.1.   Preliminary experiments 
 
2.1.1  Powder formulations and spray drying 
Combinations of mannitol (C*Mannidex, Cargill, Krefeld, Germany), trehalose (Treha 16400, 
Cargill, Krefeld, Germany), inositol (myo-inositol, Sigma-aldrich, Steinheim, Germany), PVP 
(Plasdone® K-25, ISP, Switzerland) and BSA (Sigma-aldrich, Steinheim, Germany) were 
prepared as 5% (wt/wt) aqueous solutions, using the ratios as shown in Table 1. The feed 
solutions supplied at a rate of 7.5 ml/min were spray dried in a Büchi B-290 spray dryer (Büchi 
Labortechnik AG, Flawil, Switzerland) with an inlet temperature set at 150ºC and an outlet 
temperature at 70-75ºC. Immediately before spray drying ND vaccine virus (LZ58 strain, kindly 
provided by Intervet, Boxmeer, the Netherlands) was added to the feed solution aiming at a 
virus titre of 1010 50% egg infectious dose (EID50) per 100 ml feed solution. A sample of 1 ml 
feed suspension was taken immediately after preparation and stored on ice until virus titration 
was performed, which was done within 3 hours. During the spray drying process the feedstock 
was kept on ice to minimize virus loss. The spray dried powder samples were stored in sealed 
glass vials at 6ºC (conditioned room) or 25ºC (incubator; Memmert INP 600, Memmert GmbH, 
Schwabach, Germany) packed in airtight aluminium bags.  
Powder vaccines without polymer or protein were prepared once while those containing 
polymers were spray dried in duplicate. Placebo powders used to assess the powder 
characteristics were spray dried in triplicate. 
 
2.1.2  Assessment of virus concentrations 
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Samples of the feed solution (1:10 dilution in Dulbecco’s phosphate buffered saline (DPBS, 
Gibco, Invitrogen, Paisley, UK)) and powders (100 mg dissolved in 1 ml DPBS) were titrated in 
specified pathogen free (SPF) chicken eggs in order to determine the loss of vaccine virus 
infectivity during spray drying. The vaccine virus titre of the powders was also determined after 
1, 6 and 12 months storage at 6ºC or 25ºC to investigate the stabilizing properties of the 
powders. Tenfold dilution series of the samples were prepared in sterile DPBS containing 1% 
penicillin-streptomycin solution (Penicillin G (10000 IU/ml)-streptomycin sulphate (10000 µg/ml) 
solution, Invitrogen, Paisley, UK). Of each dilution 100 µL was injected into the allantoic cavity of 
10-days-old embryonated SPF-eggs (4 eggs per dilution).  After incubating the eggs during 72 
hours at 37ºC the allantoic fluid of the eggs was tested for haemagglutinin activity [13]. Virus 
titres were calculated as EID50 according to Reed and Muench [14]. The detection limit was 
calculated through assumption of the minimal requirements for applying the formula of Reed 
and Muench (i.e. 3/4 infected eggs using the undiluted suspension and no infected eggs 
injected with diluted suspensions) leading to a detection limit of 102.3 EID50 per g powder. 
 
2.1.3.  Characterization of powders 
 
2.1.3.1  Moisture-related powder properties 
To determine the residual moisture content Karl Fischer titrations (Mettler DL35, Mettler Toledo, 
Zaventem, Belgium) were performed on the powder samples immediately after production. 
Powder (100-200 mg) was added to an airtight beaker containing absolute dry methanol 
(Biosolve, Valkenswaard, the Netherlands). Titration of the samples was performed using Karl 
Fischer reagent (Hydranal® Composite 2, Sigma-Aldrich, Munich, Germany). The mixture was 
stirred for 5 minutes before actual titration. All titrations were carried out in triplicate. 
The hygroscopic nature of the powders was investigated by dynamic vapor sorption (DVS 
Advantage, Surface Measurement Systems, Middlesex, UK). Using this technique, water 
sorption isotherm curves were recorded for each powder sample. Powder (10-20 mg) was 
weighed in the sample cup. Prior to exposure to various relative humidities (RH) the samples 
were dried under a stream of dry nitrogen at 25ºC until equilibrium (i.e. a weight change of less 
than 0.002% per minute during at least 15 minutes). Subsequently, the RH was increased from 
0 to 90% by steps of 10% at 25ºC allowing equilibration at each interval. 
 
2.1.3.2 Physical state of powders 
The occurrence of amorphism and crystallinity in the spray dried powders was investigated 
using differential scanning calorimetry (DSC) (DSC Q2000, TA Instruments, Zellik, Belgium). 
Samples of spray dried powders (5-10 mg) were transferred into a hermetically sealed 
aluminium cup, and after 1 min equilibration at 10ºC the temperature was increased at a rate of 
20ºC/min to 250ºC. 
 
2.1.3.3. Dry-dispersion properties of the spray dried powders 
Particle size distributions of the powders were measured within 24 hours after production by 
laser diffraction using a Malvern Mastersizer-S long bench (Malvern Instruments, Malvern, UK). 
Primary particle sizes were compared to the particle sizes measured during dry dispersion of 
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the powder to evaluate the dry dispersion properties of the powder. The obtained particle size 
parameters from the measurements were volume diameters D(v, 0.1), D(v, 0.5), D(v, 0.9). The 
results were expressed as the ratio of the particle size parameters measured by dry and wet 
dispersion (dry/wet ratio). Powders with a significant increase (P <0.05) in D(v, 0.1), D(v, 0.5) 
and D(v, 0.9) parameters upon dry dispersion (dry/wet ratio >1) were categorized as poorly dry 
dispersible. When only D(v, 0.1) significantly increased upon dry dispersion the dry-dispersibility 
of the powder was classified as ‘incomplete’. 
Measurement of the primary particle size distributions was done by the wet dispersion method 
using the 300 RF lens (Malvern Instruments, Malvern, UK). Powder samples were dispersed in 
Miglyol 812N (capric triglyceride; Sasol, Hamburg, Germany) with 0.2% Tween 80 
(polysorbate 80; Fagron, Waregem, Belgium) and subsequently sonicated to remove visible 
agglomerates. 
Dry dispersion of the powders was performed using an experimental nebulizer  consisting of a 
small compressor (OMRON CX3, Hoofddorp, the Netherlands) generating an airflow of 10 L/min 
at 2.5 bar coupled to a glass Büchner flask (Schott Duran 100 ml, Mainz, Germany) and 
expelling the powder particles via a 21 cm long plastic tube (Tygon Laboratory Tubing R3603, 
Saint-Gobain Performance Plastics, Akron (OH), USA). Powder samples were dispersed 
directly into the laser beam of the laser diffractor. During the measurements the orifice (2x10 
mm) of the disperser was held 4 cm from the laser beam and 4 cm from the lens (300 mm lens, 
Malvern Instruments, Malvern, UK). All measurements were performed in triplicate. 
 
2.2. Main experiments 
2.2.1 Powder formulations and spray drying 
Based on the stabilizing properties of the powders observed in the preliminary experiments, 
mannitol, inositol and BSA were selected as powder compounds in the main experiments. A 
modified simplex centroid mixture design [15] was carried out to investigate the influence of 
each stabilizer on vaccine stability (i.e. remaining vaccine titre), the residual moisture content 
and the hygroscopicity after spray drying. To assure sufficient powder yield after spray drying, 
each formulation contained a minimum of 60% mannitol as concluded from other experiments 
(unpublished results). The ratios between mannitol, inositol and BSA were varied as shown in 
Table 3. Three centre points were included in the design to allow random error estimation. The 
design was generated and analyzed using MODDE software (MODDE 9.0, Umetrics, Sweden) 
[15]. 
Formulations were prepared as 10% (w/w) aqueous solutions with approximately 1010 EID50 of 
ND vaccine virus (LZ58) per 100 ml and subsequently spray dried using a Büchi B-290 lab scale 
spray dryer at the same settings as for the powders of the preliminary experiments. Placebo 
powders were spray dried in triplicate to determine the powder characteristics. 
 
2.2.2. Assessment of virus concentrations and powder characteristics 
Virus titres of the feed solutions and spray dried powders were determined by virus titrations in 
chicken SPF-eggs immediately after production and after 1 and 6 months storage at 6ºC or 
25ºC. Titrations were performed as described in ‘Assessment of virus concentrations’ (2.1.2). 
The detection limit was 102.3 EID10 per g powder. 
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Placebo powders were characterized immediately after production for moisture content, 
hygroscopicity at 60% RH and dry dispersion properties as described previously (2.1.3). The 
morphology of the spray dried samples was examined by scanning electron microscopy (SEM) 
(SEM Quanta 200F, FEI, Hillsboro (OR), USA). To improve the electron conductivity of the 
samples a gold coating of approximately 40 nm was sputtered onto the samples. 
 
2.3. Statistical analysis 
The moisture content data and particle size parameters of the preliminary experiments obtained 
by wet and dry dispersion were statistically evaluated by a one-way ANOVA (SPSS 16.0; SPSS, 
Chicago (IL), USA) and checked for homogeneity of variances using the Levene test. Log-
transformation of data was performed when needed to obtain good homogeneity of variances.  
The dry and wet dispersion data of the powders from the main experiments were analysed in 
the same way. The raw data of the remaining vaccine titre (%) after spray drying and storage 
were evaluated by means of a replicate plot (MODDE 9.0, Umetrics, Sweden). A replicate plot 
evaluates the random variability of the data versus the variability obtained by changing factors. 
The data of residual moisture content and hygroscopicity of the samples were also analysed 
using this software and plots of the scaled and centred model coefficients were generated.   
 
3. RESULTS 
 
3.1. Preliminary experiments 
3.1.1. ND vaccine virus concentrations after spray drying and storage 
The virus titre of the feeds ranged from 109.0-10.5 EID50 per 100 ml for both the preliminary and 
the main experiments. The loss of virus titre after spray drying of the ND vaccine containing 
feeds and after storage of the powders at 6ºC or 25ºC is shown in Table 1. The 
mannitol/trehalose combination led to the highest titre loss after spray drying (2.9 log10 EID50), 
while a loss of 1 log10 EID50 was observed using the combination of mannitol with inositol. The 
virus titres in the powder formulations containing also PVP and/or BSA were reduced by 1.3-2.6 
log10 EID50 after spray drying. 
After 12 months storage the powder vaccine titres declined more severely when stored at 25ºC 
than at 6ºC, resulting in final vaccine titres below the detection limit (102.3 log10 EID50/g) for most 
powder formulations. The vaccine stability in the powders did not depend on the use of 
trehalose or inositol as similar results were obtained for both powder series. However, the 
presence of BSA in the powder formulation enhanced the vaccine stability when powders were 
stored during 12 months at 6ºC, losing between 0.7 – 1.7 log10 EID50, regardless whether BSA 
was used together with PVP or not.  
 
3.1.2. Moisture-related powder properties 
Although the moisture contents of all powders were low (max. 1.5%), adding PVP and/or BSA 
significantly (P <0.05) increased the moisture content of powders (Table 2). This effect was 
more pronounced for the trehalose powders, as shown also by the water sorption experiments 
(Fig. 1). The water uptake by trehalose powders was generally higher than that of inositol 
powders: a maximal water uptake of 8.7% was observed at 90% RH in case of the 
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mannitol/trehalose/PVP/BSA formulation, while the mannitol/inositol/PVP/BSA powder 
contained 3.2% water at 90% RH. 
 
3.1.3. Physical state of powders 
According to the DSC-results presented in Table 2, all powders were crystalline with a melting 
peak around 160ºC due to the presence of mannitol. However, except for the mannitol/inositol 
formulation, glass transition temperatures were observed in the powders, indicating that these 
powder matrices are not purely crystalline, but are to a certain degree also amorphous. PVP-
containing powders showed the highest glass transition temperatures (Tg= 88-90ºC), followed 
by the mannitol/trehalose powder (Tg= 73ºC).  
 
3.1.4. Dry-dispersion properties of the spray dried powders 
The D(v, 0.1), D(v, 0.5) and D(v, 0.9) of the powders when measured in wet dispersion mode 
ranged from 1.7 to 13.3 µm, 7.5 to 62.7 µm and 17.5 to 221.5 µm, respectively. Table 2 shows 
the dry/wet ratio of the particle size parameters when measured by wet dispersion (primary 
particle size) and by dry dispersion method immediately after production. All powders had a 
significantly higher D(v, 0.1) after dry dispersion, while D(v, 0.5) and D(v, 0.9) were similar upon 
wet and dry dispersion. This indicated that only the smallest particles could not be 
deagglomerated via the dry dispersion method and the dispersibility of the powders was 
categorized as incomplete via the dry-dispersion method. 
 
3.2. Main experiments 
No valid model could be calculated for vaccine loss after spray drying and storage, however 
some trends could be observed from the individual experiments (Table 3).  
The highest titre loss, being 4.5 log10 EID50, occurred when only mannitol was used during spray 
drying. Integrating inositol and/or BSA in the mannitol matrix limited the titre loss to 1.4-3.7 log10 
EID50, depending on the ratio of the stabilizer compounds. In general, inositol concentrations 
≥20% in the mannitol-matrix resulted in higher titre loss after spray drying (2.9-3.7 log10 EID50) in 
comparison with BSA-containing powders (± 2 log10 EID50), with the exception of 
mannitol/inositol/BSA (60:20:20) which lost only 1.4 log10 EID50. 
When stored for 1 month at 6ºC notable titre losses were observed for only 2 formulations: 
formulation 2 (mannitol/inositol (60:40)) with 1.1 log10 EID50 and formulation 10 
(mannitol/inositol/BSA (73.3:13.3:13.3)) with 0.8 log10 EID50. The decline in vaccine titre was 
more pronounced when the powder vaccines were stored at 25ºC during the same period. 
Exceptions were formulations 11 and 12 (a replicate of 11) in which no loss of vaccine was 
observed. In contrast formulation 10, having identical composition as formulation 11 and 12, did 
show vaccine titre loss after 1 month storage. 
Titre losses after storage during 6 months at 6ºC were relatively low (max. 1.6 log10 EID50 for 
mannitol/inositol (60:40)), while stored at 25ºC the titre of mannitol (100%) and 
mannitol/inositol/BSA (60:20:20) dropped below the detection limit (102.3 EID50/g).  
Higher BSA concentrations in the powder increased moisture content and hygroscopicity of the 
formulations as indicated by the coefficient plots in Fig. 2. The highest moisture content (3.5%) 
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and water uptake at 60% RH (5.6%) was found for the powder formulation with the highest BSA 
content (mannitol/BSA (60:40); Table 3).  
When measured in wet dispersion the D(v, 0.1), D(v, 0.5) and D(v, 0.9) of the powders ranged 
from 2.1 to 15.4 µm, 7.7 to 193.0 µm and 15.8 to 449.0 µm, respectively. The dry dispersibility 
of the powders is outlined in Table 3. Powders with ≥20% BSA showed incomplete to poor 
deagglomeration of the particles upon dry dispersion.  
The powder particle morphology (Fig. 3) was mainly influenced when 40% of inositol or BSA 
was present in the powders: spray drying 100% mannitol resulted in spherical particles (Fig. 
3A), while the spray dried powder mannitol/inositol (60:40) consisted of large agglomerates (Fig. 
3B) and mannitol/BSA (60:40) of strongly corrugated particles (Fig. 3C). In other powders such 
as the mannitol/inositol/BSA formulation (73.3:13.3:13.3) in Fig. 3 J, K and L (clusters of) 
spherical particles were observed. 
 
4. DISCUSSION 
Immediately after spray drying the ND powder vaccines were evaluated on several aspects: 
1) ND vaccine stability in the powder during production and storage; 2) dry dispersibility of the 
powder into its primary particles and 3) moisture content and hygroscopicity. 
To limit the ND vaccine titre loss in the mannitol-matrix during spray drying the 
incorporation of trehalose, inositol or polymers such as PVP and/or BSA was required: a 
reduction in titre loss from 4.5 log10 EID50 in the mannitol powder (Table 3) to 1.3-2.9 log10 EID50 
(Table 1) in the preliminary experiments was achieved. The amorphous fractions in the 
crystalline mannitol-matrix induced by trehalose, BSA or PVP could have added to the vaccine 
stability during spray drying by preserving its structural integrity through immobilization in a 
glassy matrix (vitrification) [16]. However, in the mannitol/inositol powder of the preliminary 
experiments no glass transition temperature was measured, while only 1 log10 EID50 was lost 
after spray drying. It is possible that the amorphous phase induced by inositol remained 
undetected by DSC [17] or that vaccine virus stabilization mainly occurred due to hydrogen 
bond interaction between virus and inositol during drying (water replacement theory) [18]. The 
latter theory seems unlikely as the enveloped ND vaccine virus is hydrophobic [19].  
A low storage temperature was beneficial for the vaccine integrity in the powders, as 
derived from the experiments, probably because the amorphous powder structure remains 
intact when stored at temperatures well below the glass transition temperature [20] and vaccine 
degradation reactions occur slower [21]. Although high glass transition temperatures would 
keep the vaccine more stable during storage, replacing PVP by BSA enhanced vaccine virus 
stability (Table 1). Probably other stabilizing mechanisms such as hydrophobic interaction of 
BSA [22-24] with the enveloped ND vaccine were responsible for the vaccine storage stability, 
while PVP can only engage in hydrophilic interactions [25]. 
In the main experiments mannitol was combined at varied ratios with inositol and BSA 
using a design of experiments, as inositol occurred less hygroscopic than trehalose in the 
preliminary experiments and BSA resulted in better vaccine stabilization during storage. 
Nevertheless, no valid model could be calculated for vaccine loss after spray drying and storage 
because the random variability of vaccine titre loss between the replicate samples (formulations 
10, 11 and 12) was higher than the response variability obtained by changing the ratio of the 
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compounds (formulations 1-9). This was partially due to the assay-inherent variability of 0.5-1.0 
log10 units of the virus titration [26].  
Based on the individual experiments the mannitol/inositol/BSA (73.3:13.3:13.3) 
formulation was selected as the most suitable combination for stabilizing the ND vaccine virus 
during production (virus titre loss of 1.6-2.0 log10 units) and storage (virus titre loss of 0.0-0.8 
log10 units after 6 months at 6ºC). Considering its low hygroscopicity and good dry-dispersibility 
(Table 3), the combination is qualified as a powder for inhalation. Mannitol is a well-tolerated 
sugar upon inhalation [27, 28] and is widely used in the pharmaceutical field [29] as well as in 
food industry [30]. Inositol is commonly present in food [31] and has no adverse effects after 
human oral consumption [32], however its effects upon inhalation by man or animal have not yet 
been reported. As BSA is a protein from animal origin, present in beef and cow milk, its 
consumption can in some cases provoke allergic reactions in humans [33]. Nevertheless, this 
powder combination is generally considered safe, although inhalation experiments in both man 
and animal should be performed to confirm this. 
This study did not focus on the production of powder vaccines with suitable particle size 
parameters (>20 µm for primary vaccination of young chicks, <5 µm and <10 µm for secondary 
vaccination of 2- and 4-weeks old chickens [34]) as this can be achieved by adapting the spray 
dry equipment and process. However, for the production of powders consisting of particle sizes 
exceeding 20 µm intended for primary vaccination of chickens, a higher polymer content (BSA) 
could be needed as this will favor the formation of larger droplets upon feed atomization by 
increasing the feed viscosity and so larger particles will be formed [35].  
Although these powder ND vaccines lose more vaccine titre during spray drying 
(average of 2 log10 EID50) compared to their commercially freeze-dried counterparts (up to 0.5 
log10 EID50 [36]), the titre loss of the spray dried powder vaccines after 1 year storage at 6ºC (1-
1.5 log10 EID50) approximates to that of the commercially freeze-dried ND vaccines (1-year titre 
loss of max. 1 log10 EID50 [37]). It should be considered that in this study all powders were spray 
dried at the same process parameters and the titre loss during spray drying could be decreased 
further by optimizing the spray dry process. Furthermore, the used spray dryer was a lab-scale 
model in which case the powder recipient and powder remained into contact with the exhaust air 
temperature throughout the entire process. The powder is therefore exposed to higher 
temperatures than would be achieved in larger models in which powder discharge occurs during 
spray drying [35]. The feasibility of preparing ND powder vaccines on a larger spray dryer model 
(Mobile Minor D-2000, GEA Niro, Soeborg, Denmark) was previously demonstrated [7]. 
The potential advantages of dry powder ND mass vaccination i.e. improved airborne 
vaccine stability, reduction of negative vaccinal reactions and improvement of immune response 
in the birds might overcome the higher titre loss during spray drying. This will be examined in 
future experiments in which the effects of powder ND vaccines will be compared with those of 
the currently applied liquid spray and aerosol vaccination methods in young broiler chicks.  
In conclusion, combining mannitol, inositol and BSA (in a ratio of 73.3:13.3:13.3) resulted in a 
storage-stable spray dried powder ND vaccine with a low moisture content, low hygroscopicity 
and good dry powder dispersibility.  
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Fig. 1. Huyge Preliminary experiments: Water sorption isotherms (25ºC) obtained from dynamic vapor 
sorption experiments (A) mannitol/trehalose series; (B) mannitol/inositol series. 
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Fig. 2. Huyge  Main experiments: coefficient plots of residual moisture content (A) and hygroscopicity 
(B) responses (man = mannitol; ino= inositol; BSA = Bovine Serum Albumin). Note the significant positive 
effect of BSA on the residual moisture content and hygroscopicity. 
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Fig. 3. Huyge 
 Main experiments: scanning electron microscopy images of formulations 1-12 (A-L) of which 
compositions are given in Table 3. 
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Table 1. Preliminary experiments: composition of feed solutions1 for preparation of ND powder vaccines and loss of virus titre after spray drying 
and storage (n = 2) 
 
Content (wt/wt %) Loss of virus titre (10x EID50)  
 
  
   
after 1 month 6 months 12 months 
Mannitol  Trehalose Inositol PVP  BSA 
spray 
drying 6ºC 25ºC 6ºC 25ºC 6ºC 25ºC 
Mannitol 
trehalose 
series 
90 10 - - - 2.9 1.9 2.5 - 2 - - - 
80 10 - 10 - 1.3/2.3 0.5/0.8 3.2/- 2.5/1.8 >5.73/- >5.7/3.5 >5.7/- 
80 10 - - 10 1.8/2.3 0.5/0.3 0.8/1.2 1.5/1.0 3.5/2.2 1.7/1.3 4.8/3.5 
60 20 - 10 10 2.5/1.5 0.0/0.0 1.0/0.7 0.3/0.0 3.3/2.8 0.8/0.7 >4.2/3.3 
            
  
      
Mannitol 
inositol 
series 
90 - 10 - - 1.0 0.3 3.8 1.1 3.8 2.3 >5.0 
80 - 10 10 - 2.0/2.0 1.0/0.0 2.2/2.1 1.5/- >5.2/- 2.0/-  >5.2/-  
80 - 10 - 10 2.1/1.8 1.0/0.5 1.0/0.2 1.0/0.0 2.0/2.9 1.2/1.2 3.3/>4.9 
60 - 20 10 10 2.0/1.8 0.0/0.0 0.5/0.5 0.5/1.7 2.3/3.3 1.5/0.8 >4.7/4.2 
1 5% wt/wt aqueous solutions.  
2 Not done. 
3 > Symbol indicates virus titre was below detection limit (102.3 EID50/g). 
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Table 2. Preliminary experiments: mean moisture content (n = 3), mean melting and glass transition temperature (n = 3), ratio of dry/wet particle 
size (n = 3), dry powder dispersibility and reference to results of dynamic vapor sorption experiments (n = 1) of spray dried placebo powders  
Powder formulation1 Mean 
moisture 
content ± SD 
DSC2 Ratio of dry/wet particle size Dry powder 
dispersibility 
DVS3 
 
 Tm ± SD Tg ± SD      
 
(%) (ºC) (ºC) D(v, 0.1) D(v, 0.5) D(v, 0.9) 
 
 
Mannitol trehalose  0.5 ± 0.1a 164 ± 3 73 ± 10 3.8f 0.9 0.7 incomplete 
Fig. 1A Mannitol trehalose PVP 0.8 ± 0.0
b 160 ± 2 884 1.7f 1.0 1.5 incomplete 
Mannitol trehalose BSA 1.1 ± 0.1c 160 ± 3 59 ± 3 1.4f 1.1 1.1 incomplete 
Mannitol trehalose PVP BSA 1.5 ± 0.1d 161 ± 0 58 ± 7 2.7f 0.9 1.1 incomplete 
   
89 ± 1 
    
 
        
 
Mannitol inositol 0.3 ± 0.1e 160 ± 1 - 3.6f 1.0 0.9 incomplete 
Fig. 1B Mannitol inositol PVP 0.5 ± 0.0
a 157 ± 3 86 ± 2 3.0f 0.9 0.7f incomplete 
Mannitol inositol BSA 0.5 ± 0.0a 156 ± 2 62 ± 3 3.1f 1.1 1.2 incomplete 
Mannitol inositol PVP BSA 0.5 ± 0.1a 157 ± 3 904 3.6f 1.1 0.9 incomplete 
1 Ratios of powder compounds are given in Table 1. 
2 DSC = differential scanning calorimetry experiments: Tm = melting temperature; Tg = glass transition temperature. 
3 DVS = dynamic vapor sorption experiments. 
4 Measured once. 
a – e Values with different superscript were significantly different (P <0.05). 
f Particle sizes measured by dry and wet dispersion method were significantly different (P <0.05). 
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Table 3. Main experiments: composition of feed solutions1 for preparation of ND powder vaccines and loss of virus titre after spray drying and 
storage (n = 1), mean moisture content (n = 3), water sorption at 60% RH (n = 1), ratio of dry/wet particle size (n = 3), dry powder dispersibility and 
reference to scanning electron microscopy images (n = 1) 
Formulation Content (wt/wt %) Powder vaccine Placebo powder  
    
Loss of virus titre (10xEID50) 
Mean 
moisture 
content 
± SD 
Water 
sorption 
at 60% 
RH 
Ratio of dry/wet particle size Dry powder 
dispersibility 
SEM2 
  
after 
spray 
drying 
1 month 6 months 
(%) (%) 
  
 
 
Mannitol 
 
Inositol BSA 6ºC 25ºC 6 ºC 25ºC D(v, 0.1) D(v, 0.5) D(v, 0.9)  
 
              
  
1 100 - - 4.5 0.2 1.0 0.5 >1.73 0.2 ± 0.0 0.2 0.8 1.1 1.9 good Fig. 3A 
2 60 40 - 2.9 1.1 2.1 1.6 2.8 0.1 ± 0.0 0.1 1.1 0.7a 0.8a good Fig. 3B 
3 60 - 40 2.8 0.3 0.7 0.5 3.5 3.5 ± 0.1 5.6 3.2a 0.9 1.1 incomplete Fig. 3C 
4 80 20 - 3.7 0.0 1.1 0.3 1.3 0.1 ± 0.0 0.1 1.1 0.7 1.3 good Fig. 3D 
5 80 - 20 2.2 0.0 1.3 1.0 3.3 2.0 ± 0.2 2.9 2.1a 1.1 1.0 incomplete Fig. 3E 
6 60 20 20 1.4 0.2 2.3 1.3 >5.0 0.5 ± 0.2 3.1 2.9a 1.9a 3.7a poor Fig. 3F 
7 86.7 6.7 6.7 2.1 0.2 1.0 1.2 3.7 1.0 ± 0.3 0.4 0.8 0.5a 0.5a good Fig. 3G 
8 66.7 26.7 6.7 2.9 0.3 1.3 -4 -  1.1 ± 0.0 1.0 0.4a 0.2a 0.3a good Fig. 3H 
9 66.7 6.7 26.7 2.1 0.0 1.0 1.3 4.2 2.1 ± 0.1 4.2 2.4a 1.2 1.1 incomplete Fig. 3I 
10 73.3 13.3 13.3 1.7 0.8 1.6 0.8 3.1 1.4 ± 0.2 2.1 1.1 0.8a 0.8a good Fig. 3J 
11 73.3 13.3 13.3 1.6 0.0 0.0 - -  1.1 ± 0.2 2.0 1.1 0.9a 0.9a good Fig. 3K 
12 73.3 13.3 13.3 2.0 0.0 0.0 - -  1.3 ± 0.0 1.9 1.2a 1.0 1.0 incomplete Fig. 3L 
1 10% wt/wt aqueous solutions. 
2 SEM = scanning electron microscopy.  
3 > Symbol indicates virus titre was below detection limit (102.3 EID50/g). 
4 Not done. 
a Particle sizes measured by dry and wet dispersion method were significantly different (P <0.05). 
